In addition, there is an interaction between ApoA-1 and the body's inflammatory response, which reduces the rate of liver synthesis and secretion of ApoA-1, and serum low ApoA-1 concentration can indirectly lead to increased cytokine release and strong inflammatory response against tumor cells (20, 34, 36). The gene discussed is APOA1; the disease is neoplasm.